Natera Inc
NTRA
Market Cap$11.54B
Close$
$97.68
7.2% downside
Current Fair Value
7.2% downsideOvervalued by 7.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.54 Billion |
|---|---|
| Enterprise Value | $11.02 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-3.78 |
| Beta | 1.23 |
| Outstanding Shares | 120,757,877 |
| Avg 30 Day Volume | 1,174,586 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -26.54 |
|---|---|
| PEG | 58.62 |
| Price to Sales | 13.16 |
| Price to Book Ratio | 17.55 |
| Enterprise Value to Revenue | 10.18 |
| Enterprise Value to EBIT | -24.7 |
| Enterprise Value to Net Income | -26 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.47 |
Revenue Sources
No data
ESG Score
No data
About Natera Inc
Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operat...